7/27/2022 3:17 pm
Date / Time filed with the Register of Regulations
VA.R. Document Number: R____-______
Virginia Register Publication Information

Transmittal Sheet: Response to Petition for Rulemaking
Initial Agency Notice
Agency Decision
Promulgating Board: Board of Medicine
Regulatory Coordinator: Erin Barrett


Agency Contact: William L. Harp, M.D.

Executive Director


Contact Address: Department of Health Professions

9960 Mayland Drive

Suite 300

Henrico, VA 23233
Chapter Affected:
18 vac 85 - 21: Regulations Governing Prescribing of Opioids and Buprenorphine
Statutory Authority: State: 54.1-2400 and 54.1-2928.2

Date Petition Received 07/27/2022
Petitioner Todd Lacksonen
 Petitioner's Request
The petitioner requests that the Board amend 18VAC85-21-40 to replace the requirement to co-prescribe naloxone with certain medications or conditions with a requirement to co-prescribe an FDA-approved opioid-reversal agent. 
 Agency Plan
The petition for rulemaking will be published in the Virginia Register of Regulations on August 29, 2022. The petition will also be published on the Virginia Regulatory Town Hall at www.townhall.virginia.gov to receive public comment, which will open on August 29, 2022 and will close on September 19, 2022. The Board will consider the petition and all comments in support or opposition at the next meeting after the close of public comment, currently scheduled for October 6, 2022. 
Publication Date 08/29/2022  (comment period will also begin on this date)
Comment End Date 09/19/2022